InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.640
+0.070 (2.72%)
At close: Nov 20, 2024, 4:00 PM
2.550
-0.090 (-3.41%)
After-hours: Nov 20, 2024, 7:31 PM EST
InspireMD Employees
As of December 31, 2023, InspireMD had 66 total employees, including 65 full-time and 1 part-time employees. The number of employees increased by 10 or 17.86% compared to the previous year.
Employees
66
Change (1Y)
10
Growth (1Y)
17.86%
Revenue / Employee
$103,348
Profits / Employee
-$427,818
Market Cap
68.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ALX Oncology Holdings | 72 |
electroCore | 68 |
Aligos Therapeutics | 66 |
Cue Biopharma | 53 |
Modular Medical | 40 |
Forian | 37 |
BeyondSpring | 36 |
HeartBeam | 15 |
NSPR News
- 8 days ago - InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System - GlobeNewsWire
- 6 weeks ago - InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System - GlobeNewsWire
- 2 months ago - InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System - GlobeNewsWire
- 3 months ago - InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment - GlobeNewsWire